Key result
Review details thrombolytic and beta-blocker therapies for managing AMI in elderly patients.
This review discusses the characteristics of the aging myocardium and therapeutic options, particularly thrombolytic and beta-blocker therapies, for very elderly patients with acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
Physiological changes in aging myocardium warrant cautious thrombolytic and beta-blocker use in elderly AMI; leaves optimal strategies unresolved for future trials.
Coronary artery disease is highly prevalent among the elderly, and the incidence of myocardial infarction (MI) is high. Still, the notion of optimal treatment for the elderly patient with MI remains unclear. This review will first discuss some of the characteristics of the aging myocardium that impact on the care of elderly cardiac patients. Next, the therapeutic options and their appropriateness for the aged patient are presented. Thrombolytic and beta-blocker therapies are reviewed extensively since they remain among the controversial issues in geriatric cardiology. Other well-known as well as experimental therapies are also discussed.
No takes yet. Share an insight, caveat, or question.
Forman et al. (1992) conducted a review in Acute myocardial infarction. Thrombolytic and beta-blocker therapies was evaluated. This review discusses therapeutic options, particularly thrombolytic and beta-blocker therapies, for managing acute myocardial infarction in elderly patients.
Synapse has enriched 10 related papers. Consider them for comparative context: